Skip to main content
Premium Trial:

Request an Annual Quote

Biosystems Informatics Institute Licenses Software from Pattern Expert for Proteomics Apps

NEW YORK, Aug. 31 (GenomeWeb News) - Biosystems Informatics Institute and its commercial trading arm, Turbinia, have exclusively licensed software from Pattern Expert in order to develop and market it for protein biomarker discovery.


The software has so far been used in forensics to identify car models from paint residue left at accident sites. Biosystems and Turbinia, both based in Newcastle-upon-Tyne, UK, plan to develop the software "to improve the quality of mass spectrometry data used in proteomics and other life sciences disciplines" for biomarker applications, according to a statement. The firms will begin conducting beta testing at the end of September.


Biosystems Informatics Institute, founded a year ago and funded by the UKgovernment, develops systems biology and bioinformatics software in collaboration with UKuniversities, biotechnology, and pharmaceutical companies. The institute has been working closely with Nonlinear Dynamics to develop proteomics software. Pattern Expert is located in of Borsdorf, Germany.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.